FRIAS-Fellow Ralf Reski and Greenovation Biotech cooperate on therapy for kidney diseases
Prof. Ralf Reski, FRIAS Internal Senior Fellow and head of the Freiburg Chair of Plant Biotechnology, and the biopharmaceutical company Greenovation Biotech GmbH in Heilbronn, Germany collaborate to explore the effectivity of a human protein that has been biotechnologically synthetized in moss.
By producing the human immune system protein complement factor H in moss, the scientists hope to analyse whether this protein may be used to treat specific kidney diseases. The project will run for two years.
More information can be found at the website of the University of Freiburg.